Michael Fox is a Psychiatry physician. ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1300 E Marshall St
Richmond, VA 232985028
Telephone
804-828-4570Registry record last updated 20 Dec 2021.
Clinical trials
- Safety and Feasibility of Tele-supervised Home-based Transcranial Direct Current Stimulation in Parkinson's Disease
Sponsor: Brigham and Women's Hospital
- Extramembranous and Interosseous Technique of Tibialis Posterior Tendon Transfer
Sponsor: Iva Hauptmannova
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
97.7%Atypical Antipsychotic22.2%Aripiprazole32%Quetiapine Fumarate32%Clozapine16%Olanzapine12%Risperidone9%Part D<11 patientsSSRI21.1%Trazodone Hcl35%Sertraline Hcl22%Escitalopram Oxalate20%Fluoxetine Hcl15%Paroxetine Hcl7%Part D<11 patients+ 10 more classes in this area
Cardiovascular
2.3%Beta blocker2.3%Propranolol Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
6 NIH research awards on record, funded 2002–2023 per NIH RePORTER. The latest:
- Identification of cell-type specific visual circuits in the ventral lateral geniculate nucleus
Virginia Polytechnic Inst and St Univ
FY2023$195,556R21EY033528 - Identification of cell-type specific visual circuits in the ventral lateral geniculate nucleus
Virginia Polytechnic Inst and St Univ
FY2022$245,701R21EY033528 - Virginia Tech Carilion Research Institute Translational Neurobiology Summer Undergraduate Research Fellowship (VTCRI neuroSURF)
Virginia Polytechnic Inst and St Univ
FY2022$107,718R25NS105141
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Philip Scheltens
Inserm
Rafael Tabarés‐Seisdedos
Universitat de València
Nick C. Fox
UK Dementia Research Institute
Perminder S. Sachdev
Department of Health and Aged Care
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”